ERIC WACHTER PHD - 02 Dec 2024 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role
CTO
Signature
/s/ Eric Wachter
Issuer symbol
PVCT
Transactions as of
02 Dec 2024
Net transactions value
$0
Form type
4
Filing time
04 Dec 2024, 21:43:40 UTC
Previous filing
22 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVCT Stock Options (Right to Buy) Award $0 +2,138,548 $0.000000 2,138,548 02 Dec 2024 Common Stock 2,138,548 $0.2862 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in three equal annual installments beginning on December 2, 2024.